Docusign (NASDAQ:DOCU) Price Target Cut to $52.00 by Analysts at Piper Sandler

Docusign (NASDAQ:DOCU) had its price objective trimmed by Piper Sandler from $75.00 to $52.00 in a research note published on Wednesday morning,Benzinga reports. The firm currently has a neutral rating on the stock.

Other research analysts have also recently issued research reports about the stock. Bank of America cut their price objective on shares of Docusign from $102.00 to $82.00 and set a “neutral” rating on the stock in a research report on Friday, December 5th. Evercore lowered their target price on shares of Docusign from $92.00 to $80.00 and set an “in-line” rating for the company in a report on Friday, December 5th. Needham & Company LLC reaffirmed a “hold” rating on shares of Docusign in a research note on Tuesday, March 10th. Weiss Ratings reiterated a “hold (c)” rating on shares of Docusign in a report on Wednesday, January 21st. Finally, Wells Fargo & Company reduced their price objective on shares of Docusign from $75.00 to $60.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Five equities research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Docusign currently has a consensus rating of “Hold” and a consensus target price of $66.67.

Docusign Stock Performance

Shares of Docusign stock opened at $48.90 on Wednesday. The stock has a market cap of $9.79 billion, a price-to-earnings ratio of 33.04, a price-to-earnings-growth ratio of 2.07 and a beta of 1.03. The stock has a 50 day moving average price of $50.69 and a 200-day moving average price of $64.35. Docusign has a one year low of $40.16 and a one year high of $94.67.

Docusign (NASDAQ:DOCU) last released its earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.06. Docusign had a return on equity of 16.70% and a net margin of 9.60%.The firm had revenue of $836.86 million for the quarter, compared to the consensus estimate of $828.23 million. During the same quarter in the previous year, the company posted $0.86 EPS. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. Sell-side analysts predict that Docusign will post 1.17 earnings per share for the current fiscal year.

Docusign announced that its board has authorized a stock repurchase program on Tuesday, March 17th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to purchase up to 21% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s management believes its shares are undervalued.

Insider Activity at Docusign

In related news, CEO Allan C. Thygesen sold 26,250 shares of Docusign stock in a transaction dated Friday, January 9th. The shares were sold at an average price of $69.60, for a total transaction of $1,827,000.00. Following the completion of the sale, the chief executive officer owned 142,261 shares in the company, valued at $9,901,365.60. This trade represents a 15.58% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CRO Paula Hansen sold 6,000 shares of the business’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $67.05, for a total transaction of $402,300.00. Following the completion of the sale, the executive directly owned 68,970 shares of the company’s stock, valued at approximately $4,624,438.50. This trade represents a 8.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 51,477 shares of company stock valued at $3,521,607 over the last ninety days. Company insiders own 1.01% of the company’s stock.

Hedge Funds Weigh In On Docusign

A number of institutional investors have recently modified their holdings of the stock. Central Pacific Bank Trust Division bought a new stake in shares of Docusign during the fourth quarter valued at approximately $25,000. Modus Advisors LLC bought a new position in Docusign in the fourth quarter worth approximately $27,000. Torren Management LLC purchased a new position in Docusign during the 4th quarter worth $28,000. True Wealth Design LLC increased its holdings in Docusign by 105.2% during the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after purchasing an additional 222 shares during the period. Finally, Aventura Private Wealth LLC bought a new stake in Docusign during the 4th quarter valued at $30,000. 77.64% of the stock is owned by hedge funds and other institutional investors.

More Docusign News

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q4 results and FY27 outlook beat estimates — DocuSign reported adjusted EPS of $1.01 and revenue of $836.9M, topping Street forecasts and signaling continued subscription growth and momentum into fiscal 2027. Docusign’s Q4 Earnings and Revenues Surpass Estimates, Increase Y/Y
• Positive Sentiment: Share‑repurchase boost — Management authorized a $2.0 billion increase to the buyback program, a direct capital‑return action that supports EPS and signals confidence from the board. PR Newswire: Share Repurchase Increase
• Positive Sentiment: Product traction in IAM and AI — Management highlighted strong IAM ARR (> $350M after 18 months) and plans to grow IAM share and AI partnerships, supporting secular expansion beyond e‑signatures. Seeking Alpha: IAM ARR and AI Partnerships
• Neutral Sentiment: Analysts and investors want higher top‑line acceleration — Coverage notes that while results showed traction, many want to see sustained >10% revenue growth before committing, leaving some investors on the sidelines. MSN: Analysts Wait for 10%+ Revenue Growth
• Neutral Sentiment: Some buy ratings remain — BTIG reaffirmed a buy with a $70 target, showing pockets of analyst optimism despite broad caution. Benzinga: BTIG Reaffirms Buy
• Negative Sentiment: Broad downward revisions to price targets — Multiple firms (Citigroup, Morgan Stanley, JPMorgan, UBS, Wells Fargo, RBC, Piper Sandler, Baird, others) cut targets after the print, reflecting concerns about growth runway and execution; that pressure caps upside even with the beat. Blockonomi: Analyst Targets Slashed TickerReport: Citigroup Cut
• Negative Sentiment: Valuation and growth trade‑offs highlighted — Analysts trimmed fair‑value estimates and flagged pricing/AI competition risks, underscoring why some investors remain cautious despite product progress. Yahoo Finance: Valuation and AI Risks

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.